Preparation and in vitro evaluation of imiquimod loaded polylactide-based micelles as potential vaccine adjuvants (Q38953988)

7 September 2017

title

Preparation and in vitro evaluation of imiquimod loaded polylactide-based micelles as potential vaccine adjuvants (English)

1 reference

7 September 2017

0 references

6

Didier Gigmes

1 reference

7 September 2017

author name string

Gloria Jiménez-Sánchez

1

1 reference

7 September 2017

Vincent Pavot

2

1 reference

7 September 2017

Christelle Chane-Haong

3

1 reference

7 September 2017

Nadège Handké

4

1 reference

7 September 2017

Céline Terrat

5

1 reference

7 September 2017

Thomas Trimaille

7

1 reference

7 September 2017

Bernard Verrier

8

1 reference

7 September 2017

language of work or name

1 reference

24 September 2014

1 reference

7 September 2017

published in

Pharmaceutical Research

1 reference

7 September 2017

volume

32

1 reference

7 September 2017

issue

1

1 reference

7 September 2017

page(s)

311-320

1 reference

Adjuvants for human vaccines

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Alum adjuvant: some of the tricks of the oldest adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Vaccine entrapment in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Polymeric particles in vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Programming the magnitude and persistence of antibody responses with innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Unleashing the therapeutic potential of NOD-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Targeting dendritic cells with biomaterials: developing the next generation of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Treatment of genital warts with an immune-response modifier (imiquimod).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Elaboration of glycopolymer-functionalized micelles from an N-vinylpyrrolidone/lactide-based reactive copolymer platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Protein modification with amphiphilic block copoly(2-oxazoline)s as a new platform for enhanced cellular delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Disulfide-crosslinked polyion micelles for delivery of protein therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Imiquimod: mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Imiquimod inhibits the differentiation but enhances the maturation of human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Poly(I:C) coated PLGA microparticles induce dendritic cell maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Potential of NOD receptor ligands as immunomodulators in particulate vaccine carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1465-5

Imiquimod applied topically: a novel immune response modifier and new class of drug

21 January 2018

1 reference

12 December 2020

Exploiting lymphatic transport and complement activation in nanoparticle vaccines

1 reference

12 December 2020

Lysine-tagged peptide coupling onto polylactide nanoparticles coated with activated ester-based amphiphilic copolymer: a route to highly peptide-functionalized biodegradable carriers

1 reference

12 December 2020

The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans' cells

1 reference

12 December 2020

Polymer micelles with pyridyl disulfide-coupled antigen travel through lymphatics and show enhanced cellular responses following immunization

1 reference

12 December 2020

Effect of poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles

1 reference

12 December 2020

TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation

1 reference

12 December 2020

10.1007/S11095-014-1465-5

Identifiers

DOI

1 reference

7 September 2017

1 reference